Modeling HIV persistence, the latent reservoir, and viral blips

L Rong, AS Perelson - Journal of theoretical biology, 2009 - Elsevier
HIV-1 eradication from infected individuals has not been achieved with the prolonged use of
highly active antiretroviral therapy (HAART). The cellular reservoir for HIV-1 in resting …

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1

MC Strain, SJ Little, ES Daar, DV Havlir… - The Journal of …, 2005 - academic.oup.com
Patients in whom virologic suppression is achieved with highly active antiretroviral therapy
(HAART) retain long-lived cellular reservoirs of human immunodeficiency virus type 1 (HIV …

Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy

L Rong, AS Perelson - PLoS computational biology, 2009 - journals.plos.org
Although potent combination therapy is usually able to suppress plasma viral loads in HIV-1
patients to below the detection limit of conventional clinical assays, a low level of viremia …

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence

MC Strain, HF Günthard, DV Havlir… - Proceedings of the …, 2003 - National Acad Sciences
Viral replication and latently infected cellular reservoirs persist in HIV-infected patients
achieving undetectable plasma virus levels with potent antiretroviral therapy. We exploited a …

Adaptation in the env Gene of HIV-1 and Evolutionary Theories of Disease Progression

S Williamson - Molecular biology and evolution, 2003 - academic.oup.com
The exact mechanisms by which HIV overwhelms the immune system remain poorly
understood. Among the several explanations of HIV disease progression, most include …

Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips

L Rong, AS Perelson - Mathematical biosciences, 2009 - Elsevier
Most HIV-infected patients when treated with combination antiretroviral therapy achieve viral
loads that are below the current limit of detection of standard assays after a few months …

Viral and latent reservoir persistence in HIV-1–infected patients on therapy

H Kim, AS Perelson - PLoS computational biology, 2006 - journals.plos.org
Despite many years of potent antiretroviral therapy, latently infected cells and low levels of
plasma virus have been found to persist in HIV-infected patients. The factors influencing this …

A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients

JM Conway, D Coombs - PLoS computational biology, 2011 - journals.plos.org
Motivated by viral persistence in HIV+ patients on long-term anti-retroviral treatment (ART),
we present a stochastic model of HIV viral dynamics in the blood stream. We consider the …

Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers

JM Conway, AS Perelson, JZ Li - PLoS computational biology, 2019 - journals.plos.org
Antiretroviral therapy (ART) effectively controls HIV infection, suppressing HIV viral loads.
Suspension of therapy is followed by rebound of viral loads to high, pre-therapy levels …

Pharmaceutical approaches to eradication of persistent HIV infection

MC Bowman, NM Archin, DM Margolis - Expert reviews in molecular …, 2009 - cambridge.org
Highly active antiretroviral therapy (HAART) has markedly decreased morbidity and mortality
in human immunodeficiency virus type 1 (HIV-1)-infected individuals in the developed world …